Screening for pre‐eclampsia with competing‐risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestation

Documenti analoghi

• OC17.02: Adherence to guideline‐recommended aspirin for pre‐eclampsia prevention in Denmark
  di: I. Riishede, et al.
  Pubblicazione: (2024)
• Timing of blood sample collection in combined first‐trimester screening for chromosomal aberrations and pre‐eclampsia screening
  di: I. Riishede, et al.
  Pubblicazione: (2025)
• Predictive performance of Fetal Medicine Foundation first‐trimester screening algorithm for pre‐eclampsia according to conception mode
  di: A. S. L. Kjaer, et al.
  Pubblicazione: (2026)
• Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
  di: N. Sokratous, et al.
  Pubblicazione: (2024)
• Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses
  di: A. Arechvo, et al.
  Pubblicazione: (2024)